Easai – Promising Alzheimer’s Drug?
February 10, 2022 at 09:31 AM EST
I saw this in Alzheimer’s research news. I wondered if Eisai looks like a strong company. Robinhood gives it 50% hold, 25% buy, 25%sell. From the Field: Aducanumab Approved for Treatment of Alzheimer’s disease (AD) On June 2021, the US Food and Drug Administration (FDA) gave ‘accelerated approval’ for the anti-amyloid drug aducanumab, which is […]
